- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01175681
Effect of Remote Ischemia Preconditioning on Myocardial Injury in Patients Undergoing Heart Valve Surgery
July 20, 2011 updated by: Sun Yat-sen University
Remote ischaemic preconditioning has shown its cardiac protective effect during heart surgery including coronary artery bypass graft surgery, congenital heart disease and aneurysm.
However, no data was reported on heart valve disease surgery.
Rheumatic heart disease is one of the major heart diseases requiring surgery in China.
Thus, the investigators chose heart valve disease as a focus to see whether remote ischaemic preconditioning also has cardiac protective effect during heart valve surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
73
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510180
- Guangzhou First Municipal People's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All heart valve diseases needing heart valve surgery.
Exclusion Criteria:
- All four limbs existed ischemic condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: untreated
control
|
|
|
EXPERIMENTAL: treatment
remote ischaemic preconditioning
|
Remote ischaemic preconditioning consisted of three 5-min cycles of right upper arm ischaemia, which was induced by an automated cuff -inflator placed on the right upper arm and inflated to 200 mm Hg, with an intervening 5 min of reperfusion during which the cuff was deflated.
There was a 5- to 10-min interval between completion of the remote ischaemic preconditioning protocol and initiation of bypass.Control patients had a deflated cuff placed on the right upper arm for 30 min.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
plasma troponin I level
Time Frame: with 7 days after surgery
|
The investigators will measure the plasma troponin I level in several time points before and after surgery in each patient.
|
with 7 days after surgery
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
serum creatinine
Time Frame: within 7 days after surgery
|
within 7 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007 Aug 18;370(9587):575-9. doi: 10.1016/S0140-6736(07)61296-3.
- Xie JJ, Liao XL, Chen WG, Huang DD, Chang FJ, Chen W, Luo ZL, Wang ZP, Ou JS. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing heart valve surgery: randomised controlled trial. Heart. 2012 Mar;98(5):384-8. doi: 10.1136/heartjnl-2011-300860. Epub 2011 Nov 22.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2007
Primary Completion (ACTUAL)
March 1, 2011
Study Completion (ACTUAL)
June 1, 2011
Study Registration Dates
First Submitted
August 3, 2010
First Submitted That Met QC Criteria
August 4, 2010
First Posted (ESTIMATE)
August 5, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
July 21, 2011
Last Update Submitted That Met QC Criteria
July 20, 2011
Last Verified
July 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ischemia
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Valve Diseases
-
National University of Ireland, Galway, IrelandNot yet recruitingSurgical Valve Replacement | AORTIC VALVE DISEASES | Valve Disease, Aortic | Valve-in-valve ProceduresIreland
-
IRCCS Policlinico S. DonatoRecruitingMitral Valve Prolapse | Myxomatous Mitral Valve DegenerationItaly
-
Centro Cardiologico MonzinoAzienda Ospedaliero-Universitaria di Parma; Policlinico SS Annunziata di ChietiActive, not recruitingMitral Regurgitation | Mitral Valve ProlapseItaly
-
Michael MorontRecruitingValve Disease, Heart | Valve Replacement | Valve Heart Stenosis | Valve Regurgitation, MitralUnited States
-
Meril Life Sciences Pvt. Ltd.Not yet recruitingAortic Valve Disease, Mitral Valve Disease, Prosthetic Heart Valve Dysfunction | Valvular Heart Disease Requiring Surgical Aortic or Mitral Valve Replacement
-
TRiCaresRecruitingCardiovascular Diseases | Heart Valve Disease | Tricuspid Valve RegurgitationBelgium, Germany
-
University of SalernoActive, not recruitingMitral Valve Failure | AORTIC VALVE DISEASESItaly
-
National Heart, Lung, and Blood Institute (NHLBI)WithdrawnHeart Failure | Aortic Valve Stenosis | Mitral Valve Regurgitation | Heart Valve Disease | Tricuspid Valve RegurgitationUnited States
-
Boston Children's HospitalRecruitingValve Disease, Heart | Valve Heart Disease | Valve Disease, AorticUnited States
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, WisconsinCompletedMitral Valve Regurgitation | Tricuspid Valve Regurgitation, Non-rheumaticUnited States
Clinical Trials on remote ischaemic preconditioning
-
University of NottinghamCompletedVascular Diseases | HypertensionUnited Kingdom
-
Western University, CanadaAcademic Medical Organization of Southwestern OntarioTerminatedCardiovascular Diseases | Hemodialysis
-
University College London HospitalsCompletedCoronary Heart DiseaseUnited Kingdom
-
University College, LondonUniversity College London HospitalsUnknownCardiotoxicityUnited Kingdom
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingIschemic PreconditioningChina
-
Mid Western Regional Hospital, IrelandCompletedContrast Induced Nephropathy | Remote Ischaemic PreconditioningIreland
-
University College, LondonUniversity College London Hospitals; National Hospital for Neurology and Neurosurgery...Unknown
-
The University of Hong KongCompleted
-
NHS National Waiting Times Centre BoardUniversity of Glasgow; Chief Scientist Office of the Scottish Government; Chest...CompletedCoronary Disease | Ischemic PreconditioningUnited Kingdom
-
University College, LondonCompletedCoronary Heart DiseaseUnited Kingdom